Moderna (MRNA) PT Lowered to $143 at UBS, shares 'undervalued'

November 6, 2023 5:57 AM EST Send to a Friend
UBS analyst Eliana Merle lowered the price target on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login